Literature DB >> 3337907

Plasma cell karyotype in multiple myeloma.

J Gould1, R Alexanian, A Goodacre, S Pathak, B Hecht, B Barlogie.   

Abstract

Karyotypic abnormalities were studied in multiple myeloma and were correlated with clinical features. Among 115 evaluable patients, 46% had an abnormal karyotype. Trisomy 3, 5, 9, and 15 and monosomy 13 and 16 were the most common clonal abnormalities. Translocations described previously in other B cell malignancies occurred in nine patients, including four with t(8;14)(q24;q32) translocations. The association of all t(8;14) abnormalities with IgA protein type suggested a pathogenetic relationship between a specific karyotypic abnormality and myeloma protein type. Hypodiploidy occurred mainly in patients with only Bence Jones protein, was associated with resistance to therapy, and justified the early consideration of investigational therapies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3337907

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Proto-oncogene analysis in multiple myeloma.

Authors:  M Ladanyi; S Wang; R Niesvizky; H Feiner; J Michaeli
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

2.  Cytogenetics in multiple myeloma and plasma cell leukemia: simultaneous cytogenetic and cytologic studies in 51 patients.

Authors:  K Gutensohn; H J Weh; T A Walter; D K Hossfeld
Journal:  Ann Hematol       Date:  1992-08       Impact factor: 3.673

3.  Suppression of abnormal karyotype predicts superior survival in multiple myeloma.

Authors:  V Arzoumanian; A Hoering; J Sawyer; F van Rhee; C Bailey; J Gurley; J D Shaughnessy; E Anaissie; J Crowley; B Barlogie
Journal:  Leukemia       Date:  2008-01-17       Impact factor: 11.528

Review 4.  Multiple myeloma: increasing evidence for a multistep transformation process.

Authors:  M Hallek; P L Bergsagel; K C Anderson
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

5.  In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes.

Authors:  Erming Tian; Jeffrey R Sawyer; Christoph J Heuck; Qing Zhang; Frits van Rhee; Bart Barlogie; Joshua Epstein
Journal:  Genes Chromosomes Cancer       Date:  2014-03-17       Impact factor: 5.006

6.  A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.

Authors:  Wee Joo Chng; Scott A Van Wier; Gregory J Ahmann; Jerry M Winkler; Syed M Jalal; Peter Leif Bergsagel; Marta Chesi; Mike C Trendle; Martin M Oken; Emily Blood; Kim Henderson; Rafael Santana-Dávila; Robert A Kyle; Morie A Gertz; Martha Q Lacy; Angela Dispenzieri; Philip R Greipp; Rafael Fonseca
Journal:  Blood       Date:  2005-05-26       Impact factor: 22.113

Review 7.  Molecular aspects of multiple myeloma.

Authors:  G Pratt
Journal:  Mol Pathol       Date:  2002-10

8.  Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes.

Authors:  D Tabernero; J F San Miguel; M Garcia-Sanz; L Nájera; M García-Isidoro; J A Peréz-Simon; M Gonzalez; J Wiegant; A K Raap; A Orfão
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

9.  Autoregulatory circuits in myeloma. Tumor cell cytotoxicity mediated by soluble CD16.

Authors:  R G Hoover; C Lary; R Page; P Travis; R Owens; J Flick; J Kornbluth; B Barlogie
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

10.  An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene.

Authors:  H Rosenbaum; A W Harris; M L Bath; J McNeall; E Webb; J M Adams; S Cory
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.